Testosterone and Inflammation: The Hormonal Link Between Low T and Chronic Disease

Testosterone is the dominant androgen in men and an important hormone in women, produced primarily in the testes and ovaries with smaller contributions from the adrenal glands. Its roles in sexual function, muscle mass, bone density, and mood are well recognized. Less discussed in popular health media is testosterone's significant role as an immune modulator with direct anti-inflammatory effects that influence systemic inflammatory status throughout the lifespan.

Low testosterone, formally defined as hypogonadism in men (total testosterone below 300 ng/dL by most guidelines), is increasingly prevalent, affecting an estimated 20 percent of men over 60 and, by some estimates, declining at the population level in Western nations independently of the aging effect. The relationship between low testosterone and chronic inflammatory disease is bidirectional and clinically significant, with implications for cardiovascular disease prevention, metabolic health, and the management of conditions where inflammation plays a central role.

Testosterone's Direct Anti-Inflammatory Mechanisms

Testosterone exerts direct anti-inflammatory effects through androgen receptors expressed on key immune cell populations. In macrophages, testosterone binding to androgen receptors suppresses NF-kB activation and reduces production of TNF-alpha, IL-6, and IL-1 beta, shifting macrophage polarization toward the anti-inflammatory M2 phenotype. In T-cells, testosterone promotes regulatory T-cell differentiation and suppresses Th1 and Th17 inflammatory T-cell activity, reducing the adaptive immune inflammatory response. In endothelial cells, testosterone upregulates eNOS activity and nitric oxide production, improving vascular function and reducing endothelial inflammatory activation.

Testosterone also suppresses the production of acute-phase proteins in the liver, including CRP and fibrinogen, through direct hepatic androgen receptor signaling. This hepatic anti-inflammatory effect explains the consistent inverse association between testosterone levels and CRP in cross-sectional studies: men with higher testosterone reliably have lower CRP, and this relationship persists after adjustment for BMI, physical activity, and other confounders. Multiple meta-analyses have confirmed that serum testosterone is inversely associated with CRP, IL-6, and TNF-alpha in both men and women across diverse study populations.

Low Testosterone and Inflammatory Disease Risk

The consequences of chronically low testosterone extend well beyond sexual function and body composition. Low testosterone is independently associated with elevated cardiovascular disease risk, type 2 diabetes, metabolic syndrome, osteoporosis, cognitive decline, and all-cause mortality in prospective studies. A substantial portion of these associations is mediated through the pro-inflammatory state that accompanies low testosterone. Men with the lowest testosterone quartile in the Baltimore Longitudinal Study of Aging had CRP levels 30 percent higher than those in the highest quartile, a difference that partially mediated the low testosterone groups' elevated cardiovascular mortality over follow-up.

The relationship with metabolic syndrome is particularly important. Low testosterone promotes visceral fat accumulation through impaired lipolysis, which in turn increases adipose tissue-derived inflammatory cytokines that further suppress testosterone production through hypothalamic-pituitary axis disruption. Simultaneously, the elevated estradiol produced by aromatization of testosterone in excess visceral fat suppresses LH (luteinizing hormone) secretion from the pituitary, reducing testicular testosterone production. This testosterone-adiposity-inflammation triangle is another example of the self-perpetuating cycles that characterize chronic inflammatory disease pathophysiology.

Testosterone Therapy and Inflammatory Markers

Randomized controlled trials of testosterone replacement therapy in hypogonadal men have generally found reductions in inflammatory markers alongside the expected improvements in body composition, insulin sensitivity, and cardiovascular risk factors. A meta-analysis of 12 trials found that testosterone replacement significantly reduced CRP, IL-6, and TNF-alpha in hypogonadal men, with larger effects in men with baseline CRP above 2 mg/L. The TRAVERSE trial, the largest cardiovascular safety trial of testosterone therapy to date (5,204 hypogonadal men), found no increase in cardiovascular events and a significant reduction in incident type 2 diabetes with testosterone therapy, findings consistent with the expected anti-inflammatory and metabolic effects.

The inflammatory benefits of testosterone therapy appear to be mediated partly through direct immune modulation and partly through the body composition improvements it produces, specifically the reduction of visceral fat and the increase in metabolically active lean muscle mass. This makes it difficult to isolate the direct anti-inflammatory effect of testosterone from its downstream metabolic effects in clinical trials, though the mechanistic data strongly supports both pathways operating in parallel.

Natural Strategies for Supporting Testosterone Levels

For men and women with suboptimal testosterone levels, several lifestyle factors have well-documented effects on testosterone production. Resistance exercise is the most consistently effective natural testosterone elevator, both acutely (through post-exercise hormonal surges) and chronically (through increased lean muscle mass that improves testosterone production and sensitivity). A meta-analysis found that resistance training increased resting testosterone by an average of 14 percent in men, with larger effects in older, previously sedentary men.

Sleep is a critical determinant of testosterone production: 60 to 70 percent of daily testosterone release occurs during sleep, primarily during slow-wave sleep stages. Chronic sleep restriction below 7 hours per night reduces testosterone by 10 to 15 percent in young healthy men within a week of sleep curtailment. Maintaining healthy body weight, particularly reducing visceral adiposity, removes the aromatase-driven testosterone suppression that excess fat creates. Zinc and vitamin D, both necessary cofactors in testosterone synthesis, are commonly deficient in men with low testosterone, and correcting deficiencies improves testosterone levels in several trials. These lifestyle approaches to testosterone optimization also reduce systemic inflammation directly, creating complementary anti-inflammatory effects through both hormonal and non-hormonal pathways.